Following extensive research, Crown has claimed to have developed a supplement with superior benefits and efficacy compared to existing supplements.
The company believes that the incorporation of new changes into its intellectual property strategies in line with the amended US patent laws under the America Invents Act (AIA) will turn beneficial.
Crown is focused on the development, manufacturing and marketing of nutraceuticals and supplements.
Connecting the principles of chaos theory along with mathematical formulas for precise and programmable diffusion delivery, the company’s controlled drug delivery technology holds patents for a novel controlled-release technology.